Introduction
Understanding the mechanisms of cognitive impairment in epilepsy syndromes is essential to improving quality of life. Although emphasis has been placed on the role of seizures, etiology may contribute to cognitive dysfunction through mechanisms independent of seizures. Dravet syndrome (DS) is a life-long epilepsy syndrome with childhood onset that is associated with severe cognitive and quality-of-life impairments (Akiyama et al., 2010; Caraballo and Fejerman, 2006; Ohtsuka et al., 1991; Ragona et al., 2010; Wolff et al., 2006) . Intellectual disability in DS begins early in development and is permanent; scores on the developmental quotient typically drop to 20-40% of normal within the first 6 years of age and, as adults, IQ scores are below 50 in the majority of cases (Akiyama et al., 2010; Ohtsuka et al., 1991; Wolff et al., 2006) . Currently, emphasis has been placed on the impact of seizures, and treatments have targeted seizure control. However, amelioration of cognitive impairment with antiepileptic drugs has so far been elusive, suggesting that mechanisms other than seizures could importantly contribute to adverse outcomes.
In 85% of cases, DS is caused by mutations in the SCN1A gene, resulting in loss of function of the type I voltage-gated sodium channel (Na v 1.1). Na v 1.1 is one of four sodium channels expressed in the brain that are critical for initiating and propagating action potentials in neurons (Catterall, 2000) , and deficits in Na v 1.1 have been linked to multiple neurological disorders associated with cognitive impairment. In addition to epilepsy, SCN1A mutations have also been identified in some sporadic and familial cases of autism (O'Roak et al., 2011; Weiss et al., 2003) and are now believed to be a potential risk factor for the disorder (O'Roak et al., 2012) . Additionally, evidence of Na v 1.1 dysregulation has been found in Alzheimer's disease (AD) and has been linked to the Alzheimer's phenotype in AD mice (Kim et al., 2007; Kovacs et al., 2010; Verret et al., 2012) .
Although loss of function of Na v 1.1 has been associated with multiple neurocognitive disorders, it is unclear whether Na v 1.1 deficits contribute to cognitive impairment at all. In the context of DS, two mechanisms for cognitive impairment have been considered: (1) the presence of seizures negatively impacts cognitive development and function (Catarino et al., 2011) ; or (2) loss-of-function of Na v 1.1 impairs the normal function of neural networks that are involved in information processing (Bender et al., 2012) . It is important to acknowledge that these possibilities are not mutually exclusive and may in fact both occur simultaneously. So far, however, studies have focused primarily on the role of Na v 1.1 in seizure susceptibility rather than cognitive function (Huth and Alzheimer, 2012; Kovacs et al., Neurobiology of Disease 54 (2013) 297-307 
